Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


15.07.2024

1 AJR Am J Roentgenol
2 Am J Gastroenterol
1 Ann Intern Med
4 BMC Cancer
2 BMC Gastroenterol
2 Dig Dis Sci
4 Eur Radiol
1 Gastroenterology
2 Gut
3 Hepatology
2 Indian J Gastroenterol
1 J Comput Assist Tomogr
6 J Gastroenterol Hepatol
1 J Hepatol
1 PLoS Comput Biol
1 PLoS One
1 Semin Liver Dis


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. BRAAT AJAT, Kim HC, Vogl TJ, White SB, et al
    The Global Reading Room: A Patient With Neuroendocrine Liver Metastases After Pancreaticoduodenectomy.
    AJR Am J Roentgenol. 2023 Aug 23. doi: 10.2214/AJR.23.30113.
    PubMed        


    Am J Gastroenterol

  2. ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al
    Improvement in survival after transplantation for critically ill patients with cirrhosis in the United States.
    Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944.
    PubMed         Abstract available

  3. ASKGAARD G, Jepsen P, Jensen MD, Kann AE, et al
    Population-Based Study of Alcohol-Related Liver Disease in England in 2001-2018: Influence of Socioeconomic Position.
    Am J Gastroenterol. 2024;119:1337-1345.
    PubMed         Abstract available


    Ann Intern Med

  4. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed         Abstract available


    BMC Cancer

  5. ZHU S, Jin Y, Zhou M, Li L, et al
    KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.
    BMC Cancer. 2024;24:811.
    PubMed         Abstract available

  6. WIGG A, Tibballs J, Woodman R, Stuart K, et al
    A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC).
    BMC Cancer. 2024;24:813.
    PubMed         Abstract available

  7. WEI X, Yang C, Lin Q, Qiu M, et al
    Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study.
    BMC Cancer. 2024;24:820.
    PubMed         Abstract available

  8. ZENG J, Feng Y, Lin L, Ye H, et al
    Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25.
    BMC Cancer. 2024;24:827.
    PubMed         Abstract available


    BMC Gastroenterol

  9. ALKHOURI N, Almomani A, Le P, Payne JY, et al
    The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017-2018 cycle.
    BMC Gastroenterol. 2024;24:218.
    PubMed         Abstract available

  10. SUN J, Yan C, Wen J, Wang F, et al
    Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study.
    BMC Gastroenterol. 2024;24:221.
    PubMed         Abstract available


    Dig Dis Sci

  11. YAKUBU I, Flynn S, Khan H, Nguyen M, et al
    Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.
    Dig Dis Sci. 2024 Jul 10. doi: 10.1007/s10620-024-08499.
    PubMed         Abstract available

  12. EDELSON JC, Rockey DC
    Safety of Endoscopy in Cirrhosis.
    Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
    PubMed         Abstract available


    Eur Radiol

  13. PAN J, Huang H, Zhang S, Zhu Y, et al
    Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10944.
    PubMed         Abstract available

  14. WANG F, Zhang Q, Yan K, Jing X, et al
    3D-CEUS/MRI-CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation.
    Eur Radiol. 2024 Jul 11. doi: 10.1007/s00330-024-10915.
    PubMed         Abstract available

  15. RONOT M
    Illuminating the shades of hyper- to isointense lesions in hepatobiliary phase imaging.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10894.
    PubMed        

  16. GU K, Jeong WK, Cha DI, Hwang JA, et al
    Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10914.
    PubMed         Abstract available


    Gastroenterology

  17. LENS S
    Resmetirom for Non-alcoholic Steatohepatitis.
    Gastroenterology. 2024 Jun 25:S0016-5085(24)05120.
    PubMed        


    Gut

  18. LOOMBA R, Amangurbanova M, Bettencourt R, Madamba E, et al
    MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH.
    Gut. 2024;73:1343-1349.
    PubMed         Abstract available

  19. WANG Y, Heymann F, Peiseler M
    Intravital imaging: dynamic insights into liver immunity in health and disease.
    Gut. 2024;73:1364-1375.
    PubMed         Abstract available


    Hepatology

  20. ZHANG L, Xie P, Li M, Zhang X, et al
    Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation.
    Hepatology. 2024 Jul 10. doi: 10.1097/HEP.0000000000001003.
    PubMed         Abstract available

  21. HUANG Y, Yu F, Ding Y, Zhang H, et al
    Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver.
    Hepatology. 2024 Jul 10. doi: 10.1097/HEP.0000000000000998.
    PubMed         Abstract available

  22. HOOVER JM
    Letter to the Editor: Utilization of beta blockers in patients with portal hypertension and peripheral artery disease.
    Hepatology. 2024 Jul 8. doi: 10.1097/HEP.0000000000001008.
    PubMed        


    Indian J Gastroenterol

  23. BICHA S, Boumaraf H, Lakehal A
    Shear wave elastography as a non-invasive tool for staging liver fibrosis in children: A study in Algerian pediatric patients.
    Indian J Gastroenterol. 2024;43:601-608.
    PubMed         Abstract available

  24. EKANAYAKA SPN, Luke N, Thilakarathne SB, Dassanayake A, et al
    Characteristics and survival of advanced untreated hepatocellular carcinoma of non-viral etiology.
    Indian J Gastroenterol. 2024 Jul 10. doi: 10.1007/s12664-024-01636.
    PubMed         Abstract available


    J Comput Assist Tomogr

  25. JEPH S, Gupta S, Yedururi S, Daoud TE, et al
    Liver Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    J Comput Assist Tomogr. 2024;48:577-587.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  26. XIN Z, Chen H, Xu J, Zhang H, et al
    Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2024 Jul 7. doi: 10.1111/jgh.16677.
    PubMed         Abstract available

  27. SUGITA H, Nakanuma S, Munesue S, Ishikawa T, et al
    Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome.
    J Gastroenterol Hepatol. 2024;39:1413-1421.
    PubMed         Abstract available

  28. LIU Y, Hu Y, Li B, Su R, et al
    Innate lymphoid cell subsets in the pathogenesis of primary biliary cholangitis.
    J Gastroenterol Hepatol. 2024 Apr 12. doi: 10.1111/jgh.16547.
    PubMed         Abstract available

  29. LEE RC, Liang PC, Liang HL, Chen YF, et al
    Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.
    J Gastroenterol Hepatol. 2024;39:1318-1327.
    PubMed         Abstract available

  30. MALANDRIS K, Papandreou S, Vasilakou D, Kakotrichi P, et al
    Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta-analysis.
    J Gastroenterol Hepatol. 2024;39:1219-1229.
    PubMed         Abstract available

  31. MORI K, Akiyama Y, Tanaka M, Sato T, et al
    Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.
    J Gastroenterol Hepatol. 2024;39:1382-1393.
    PubMed         Abstract available


    J Hepatol

  32. KWON Y, Gottmann P, Wang S, Tissink J, et al
    Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease.
    J Hepatol. 2024 Jul 6:S0168-8278(24)02347-X. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available


    PLoS Comput Biol

  33. WANG M, Yan X, Dong Y, Li X, et al
    Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.
    PLoS Comput Biol. 2024;20:e1012113.
    PubMed         Abstract available


    PLoS One

  34. CHANG JJ, Lin T, Jhang XY, Chan SP, et al
    hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells.
    PLoS One. 2024;19:e0304947.
    PubMed         Abstract available


    Semin Liver Dis

  35. TINCOPA MA, Loomba R
    Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis.
    Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.